Clinical Trials Logo

Clinical Trial Summary

Background: COVID-19 affected African Americans more than Whites. African Americans, especially women, have had higher rates of COVID-19 infections compared to Whites. They are also more likely to go to the hospital or die of this disease. Many researchers who looked into these issues lacked background data on the people they studied. SELF is a 10-year study of fibroids in African American women aged 23-35. Researchers already have a lot of data on these women. Asking how COVID-19 affected them can add context other studies lack. Objective: To describe the impact of the COVID-19 pandemic on young African American women and their families. Eligibility: Participants must be enrolled in SELF (Study of Environment, Lifestyle, and Fibroids). Design: Researchers will invite all women enrolled in SELF to participate in this natural history study. Participants will complete one questionnaire. They will answer the questions online. They may also choose to get a paper copy sent by mail. The survey will take no more than 15-20 minutes. All questions will relate to COVID-19. Participants will be asked if they had COVID-19. They will be asked if family, friends, or members of their community did. They will answer questions about their vaccine status and access to health care services. Participants will also answer questions about how the pandemic affected their lives. They will be asked about their job and if finding childcare was a challenge. They will be asked about money problems and how they coped. They will be asked about sleep problems and emotional distress. Participants will get a $30 gift card after they finish the survey.


Clinical Trial Description

Study Description: This cross-sectional study will be an add-on to the Study of Environment, Lifestyle and Fibroids (SELF) (Protocol Number: 10-E-N044). SELF is a prospective cohort study of fibroid development. From November 2010 to December 2012, the study enrolled a volunteer sample recruited from Detroit, MI and surrounding areas of approximately 1,700 African-American women ages 23-35 without a diagnosis of fibroids. SELF has been a rich information source regarding the health of young African-American women. This current COVID-19 study will focus on collecting information regarding SELF participant s experiences throughout the COVID-19 pandemic through a short, one-time online questionnaire. The questionnaire will contain questions on a range of topics related to the COVID-19 pandemic to include 1) pandemic experiences in the following domains: COVID-19 illness of participant (including LONG-COVID), participant s family and friends, participants social community 2) vaccination status, 3) access to health care, 4) employment vulnerabilities and employment loss, 5) challenges with caring for children, 6) financial hardship, coping strategies, 7) sleep problems, and 8) psychosocial stressors. The questionnaire will also ask questions about COVID-19-related symptoms, vaccination, and hospitalizations experienced by the participants and/or members of her household and community. Objectives: Primary Objective: To describe the impact of the COVID-19 pandemic on reproductive-aged African American women and their families. We have three goals: First, these basic data will be summarized in a report that will be sent back to the participants. Like our newsletters, this will serve as a cohort maintenance activity, keeping our participants interested and engaged in the study. Secondly, SELF collaborators are continuing to follow the participants (the 4th follow-up is in progress, and a 5th follow-up is being planned), so these data will allow us to consider the impact of COVID-19 in future analyses. Additional studies with this cohort could also be undertaken in the future. Depending upon the exposure outcome being investigated in the data from those additional follow ups, an overall measure of impact may be important, or the impact on specific domains may be of most interest. Thirdly, we also view this study as an opportunity to document the impact of the COVID-19 pandemic, a once in a century event, in a well characterized group of reproductive-aged African-American women whose health and well-being have been followed for nearly a decade now. This is an understudied group and documenting their response to COVID will serve as one of several case-studies of specific subpopulations that are likely to emerge after the pandemic. The goal is to document the range of adverse impacts experienced and the factors (e.g., low income, limited educational attainment, pre-pandemic health conditions, neighborhood factors) that might mitigate or exacerbate those adverse impacts for this understudied demographic group. Endpoints: Primary Endpoint: Descriptive data on impact of the COVID-19 pandemic on reproductive-aged African American women and their families ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05369611
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Enrolling by invitation
Phase
Start date June 17, 2022
Completion date December 30, 2025

See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure